Paul Tan

1.7k total citations
40 papers, 1.2k citations indexed

About

Paul Tan is a scholar working on Surgery, Nephrology and Rheumatology. According to data from OpenAlex, Paul Tan has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 14 papers in Nephrology and 8 papers in Rheumatology. Recurrent topics in Paul Tan's work include Gout, Hyperuricemia, Uric Acid (14 papers), Case Reports on Hematomas (6 papers) and Dermatology and Skin Diseases (5 papers). Paul Tan is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (14 papers), Case Reports on Hematomas (6 papers) and Dermatology and Skin Diseases (5 papers). Paul Tan collaborates with scholars based in New Zealand, United States and United Kingdom. Paul Tan's co-authors include Nicola Dalbeth, Anne Horne, Robert B. Elliott, Lisa K. Stamp, Livia Escobar, Christina M. Buchanan, Jill Drake, Christopher Frampton, Anthony Doyle and Opetaia Aati and has published in prestigious journals such as Hepatology, American Journal of Respiratory and Critical Care Medicine and Annals of the Rheumatic Diseases.

In The Last Decade

Paul Tan

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Tan New Zealand 17 703 542 300 205 179 40 1.2k
Dagmar‐Christiane Fischer Germany 24 195 0.3× 375 0.7× 188 0.6× 494 2.4× 295 1.6× 77 1.7k
Gilda Clayburne United States 16 409 0.6× 496 0.9× 658 2.2× 132 0.6× 62 0.3× 33 1.2k
Satoshi Kokubo Japan 19 183 0.3× 223 0.4× 171 0.6× 339 1.7× 47 0.3× 31 1.1k
Pierre‐André Guerne Switzerland 25 251 0.4× 226 0.4× 1.0k 3.5× 407 2.0× 85 0.5× 40 1.9k
Schumacher Hr United States 18 175 0.2× 166 0.3× 472 1.6× 125 0.6× 64 0.4× 71 925
Claudia M. Gohr United States 19 139 0.2× 105 0.2× 255 0.8× 175 0.9× 59 0.3× 31 727
Leslie Robinson‐Bostom United States 25 291 0.4× 79 0.1× 301 1.0× 220 1.1× 486 2.7× 117 1.8k
Naoshi Shinozaki Japan 20 218 0.3× 196 0.4× 34 0.1× 179 0.9× 294 1.6× 32 2.4k
Ziad Khamaysi Israel 17 81 0.1× 273 0.5× 136 0.5× 347 1.7× 242 1.4× 42 1.1k
Mary H. Branton United States 6 105 0.1× 241 0.4× 212 0.7× 316 1.5× 60 0.3× 7 1.3k

Countries citing papers authored by Paul Tan

Since Specialization
Citations

This map shows the geographic impact of Paul Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Tan more than expected).

Fields of papers citing papers by Paul Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Tan. The network helps show where Paul Tan may publish in the future.

Co-authorship network of co-authors of Paul Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Tan. A scholar is included among the top collaborators of Paul Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Tan. Paul Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dalbeth, Nicola, Anthony Doyle, Greg Gamble, et al.. (2021). Intensive Serum Urate Lowering With Oral Urate‐Lowering Therapy for Erosive Gout: A Randomized Double‐Blind Controlled Trial. Arthritis & Rheumatology. 74(6). 1059–1069. 19 indexed citations
2.
Stamp, Lisa K., Peter T. Chapman, Murray L. Barclay, et al.. (2018). How much allopurinol does it take to get to target urate? Comparison of actual dose with creatinine clearance-based dose. Arthritis Research & Therapy. 20(1). 255–255. 14 indexed citations
3.
Wright, Daniel F. B., Nicola Dalbeth, Amanda Phipps‐Green, et al.. (2018). The impact of diuretic use and ABCG2 genotype on the predictive performance of a published allopurinol dosing tool. British Journal of Clinical Pharmacology. 84(5). 937–943. 15 indexed citations
4.
Stamp, Lisa K., Peter T. Chapman, Murray L. Barclay, et al.. (2017). A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout. Annals of the Rheumatic Diseases. 76(9). 1522–1528. 104 indexed citations
5.
Stamp, Lisa K., Peter T. Chapman, Murray L. Barclay, et al.. (2017). Allopurinol dose escalation to achieve serum urate below 6 mg/dL: an open-label extension study. Annals of the Rheumatic Diseases. 76(12). 2065–2070. 62 indexed citations
6.
Doyle, Anthony, Gregory D. Gamble, Paul Tan, et al.. (2016). Urate crystal deposition and bone erosion in gout: ‘inside-out’ or ‘outside-in’? A dual-energy computed tomography study. Arthritis Research & Therapy. 18(1). 208–208. 27 indexed citations
7.
Dalbeth, Nicola, Meaghan E House, Opetaia Aati, et al.. (2015). Urate crystal deposition in asymptomatic hyperuricaemia and symptomatic gout: a dual energy CT study. Annals of the Rheumatic Diseases. 74(5). 908–911. 176 indexed citations
8.
Tan, Paul, et al.. (2014). Pseudotumours and IgG4-related disease: a case report.. PubMed. 127(1395). 82–5.
9.
Aati, Opetaia, William J. Taylor, Richard J. Siegert, et al.. (2014). Development of a patient-reported outcome measure of tophus burden: the Tophus Impact Questionnaire (TIQ-20). Annals of the Rheumatic Diseases. 74(12). 2144–2150. 17 indexed citations
10.
Wang, Wei, Marilyn S. Geaney, Lee Law, et al.. (2013). Recovery of Neurological Functions in Non-Human Primate Model of Parkinson's Disease by Transplantation of Encapsulated Neonatal Porcine Choroid Plexus Cells. Journal of Parkinson s Disease. 3(3). 275–291. 28 indexed citations
11.
Tan, Paul. (2010). Company Profile: Tissue Regeneration for Diabetes and Neurological Diseases at Living Cell Technologies. Regenerative Medicine. 5(2). 181–187. 20 indexed citations
12.
Elliott, Robert B., et al.. (2007). Live encapsulated porcine islets from a type 1 diabetic patient 9.5 yr after xenotransplantation. Xenotransplantation. 14(2). 157–161. 286 indexed citations
13.
Skinner, S.J.M., Marilyn S. Geaney, Robert A. Rush, et al.. (2006). Choroid plexus transplants in the treatment of brain diseases. Xenotransplantation. 13(4). 284–288. 20 indexed citations
14.
Delcayre, Alain, et al.. (2003). A genome-based functional screening approach to vaccine development that combines in vitro assays and DNA immunization. Vaccine. 21(23). 3259–3264. 4 indexed citations
15.
Easthope, Stephanie E., Soo Cheng, Mark Weatherall, et al.. (2001). The Effect of Delipidated Deglycolipidated (DDMV) and Heat-killed Mycobacterium vaccae in Asthma. American Journal of Respiratory and Critical Care Medicine. 163(6). 1410–1414. 48 indexed citations
16.
Walsh, Douglas S., Paul Tan, Roland V. Cellona, et al.. (2000). Improvement in psoriasis after intradermal administration of heat‐killed Mycobacterium vaccae. International Journal of Dermatology. 39(1). 51–58. 20 indexed citations
17.
Sleeman, Matthew A., J. Greg Murison, Krishnanand D. Kumble, et al.. (2000). Gene Expression in Rat Dermal Papilla Cells: Analysis of 2529 ESTs. Genomics. 69(2). 214–224. 13 indexed citations
18.
Tan, Paul, et al.. (1994). The effect of prostaglandin E2 and indomethacin on the cytotoxic response to mycobacterial antigens. International Journal of Immunopharmacology. 16(7). 525–531. 3 indexed citations
19.
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dagmar‐Christiane Fischer Breakdown of academic impact, for papers by Gilda Clayburne Breakdown of academic impact, for papers by Satoshi Kokubo Breakdown of academic impact, for papers by Pierre‐André Guerne Breakdown of academic impact, for papers by Schumacher Hr Breakdown of academic impact, for papers by Claudia M. Gohr Breakdown of academic impact, for papers by Leslie Robinson‐Bostom Breakdown of academic impact, for papers by Naoshi Shinozaki Breakdown of academic impact, for papers by Ziad Khamaysi Breakdown of academic impact, for papers by Mary H. Branton
Rankless by CCL
2026